0001360604 2026-07-31 2026-07-31 0001360604 1 2026-07-31 2026-07-31 0001360604 2 2026-07-31 2026-07-31 0001360604 3 2026-07-31 2026-07-31 0001360604 4 2026-07-31 2026-07-31 0001360604 5 2026-07-31 2026-07-31 0001360604 6 2026-07-31 2026-07-31 0001360604 7 2026-07-31 2026-07-31 0001360604 8 2026-07-31 2026-07-31 0001360604 9 2026-07-31 2026-07-31 iso4217:USD pure S-3 S-3ASR EX-FILING FEES 0001360604 Healthcare Realty Trust Inc N/A N/A S-3 Healthcare Realty Trust Inc false Equity Class A common stock, $0.01 par value per share, of Healthcare Realty Trust Incorporated true 0.0001381 false Equity Preferred Stock, $0.01 par value per share, of Healthcare Realty Trust Incorporated true 0.0001381 false Other Warrants of Healthcare Realty Trust Incorporated true 0.0001381 false Debt Debt Securities of Healthcare Realty Trust Incorporated true 0.0001381 false Debt Guarantees of Debt Securities of Healthcare Realty Holdings, L.P. true 0.0001381 false Other Units of Healthcare Realty Trust Incorporated true 0.0001381 false Debt Debt Securities of Healthcare Realty Holdings, L.P. true 0.0001381 Equity Class A common stock, $0.01 par value per share, of Healthcare Realty Trust Incorporated true 250000000.00 S-3 333-273784 2023-08-08 34525.00 Equity Class A common stock, $0.01 par value per share, of Healthcare Realty Trust Incorporated true 750000000.00 S-3 333-273784 2023-08-08 81825.00 1000000000.00 0.00 0.00 0.00 0.00 Note 1.a. An unspecified number of securities or aggregate principal amount, as applicable, of each identified class is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional shares of Class A common stock, $0.01 par value per share (the "common stock"), of Healthcare Realty Trust Incorporated (the "Company") is being registered as may be issued from time to time upon conversion of any securities that are convertible into common stock or pursuant to any anti-dilution adjustments with respect to any such convertible securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also covers an indeterminate number of additional shares of common stock which may be issued with respect to such shares of common stock in connection with any stock split, stock dividend, reclassifications or similar transactions. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities. Note 1.b. In accordance with Rule 456(b) and Rule 457(r) under the Securities Act, the registrants are deferring payment of all registration fees and will pay the registration fees subsequently in advance or on a "pay-as-you-go" basis. See offering Note 1. See offering Note 1. The warrants covered by this registration statement may be common stock warrants. See offering Note 1. See offering Note 1. No separate consideration will be received for guarantees. Pursuant to Rule 457(n), no separate fee is payable with respect to the guarantees being registered hereby. The Company may fully and unconditionally guarantee the payment of principal of and premium (if any) and interest on any debt securities offered by Healthcare Realty Trust, L.P. offered pursuant to this registration statement. See offering Note 1. See offering Note 1. The Company previously registered shares of common stock having an aggregate offering price of up to $750,000,000, offered by means of a prospectus supplement, dated March 5, 2021 (the "2021 Prospectus Supplement"), pursuant to the Company's Registration Statement on Form S-3 (File No. 333-253600), filed with the Securities and Exchange Commission on February 26, 2021 (the "2021 Registration Statement"). In connection with the filing of the 2021 Prospectus Supplement, the Company made a contemporaneous fee payment to the SEC in the amount of $81,825. All such shares remained unsold and were carried forward to the Company's Registration Statement on Form S-3 (File No. 333-273784), filed with the SEC on August 8, 2023 (the "2023 Registration Statement") pursuant to Rule 415(a)(6). On December 17, 2025, the Company registered shares of common stock having an aggregate offering price of up to $1,000,000,000, offered by means of a prospectus supplement, dated December 17, 2025 (the "2025 Prospectus Supplement"), pursuant to the 2023 Registration Statement, of which shares having an aggregate offering price of $750,000,000 represented unsold securities previously registered pursuant to the 2021 Prospectus Supplement and the 2021 Registration Statement. In connection with the filing of the 2025 Prospectus Supplement, the Company made a contemporaneous fee payment in the amount of $34,525, reflecting the fee due with respect to shares of common stock to be offered and sold pursuant to the 2025 Prospectus Supplement that were not unsold securities registered pursuant to the 2021 Prospectus Supplement and the 2021 Registration Statement. Pursuant to Rule 415(a)(6) under the Securities Act, securities with an aggregate offering price of $1,000,000,000 (collectively, the "Carry Forward Securities") are unsold securities previously registered on the 2023 Registration Statement, for which filing fees of $116,350, in the aggregate, were previously paid to the Securities and Exchange Commission on the dates described above and will continue to be applied to such Carry Forward Securities. Pursuant to Rule 415(a)(6), the offering of the Carry Forward Securities under the 2023 Registration Statement was deemed terminated as of the immediate effectiveness of this registration statement. See offering Note 8.